Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

970 results
  1. NLM Digital Collections - Special assessment of outpatient treatments for COVID-19 : final evidence report and meeting .... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, May 10, 2022
    ... Ambulatory Care COVID-19 Drug Treatment Home Infusion Therapy COVID-19 is an infectious respiratory disease caused by ... the epidemiological landscape and evidence base for potential treatments for COVID-19 are both rapidly evolving and will continue ...
  2. NLM Digital Collections - Alternative policies for pricing novel vaccines and drug therapies for COVID-19 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, July 1, 2020
    ... author. Pearson, Steven D., author. COVID-19 -- drug therapy COVID-19 Vaccines -- economics The COVID-19 global pandemic ... private efforts to achieve rapid, equitable, and affordable treatment for COVID-19 in the US. [Boston, Massachusetts] : Institute for ...
  3. NLM Digital Collections - Alternative pricing models for remdesivir and other potential treatments for COVID-19 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 24, 2020
    Alternative pricing models for remdesivir and other potential treatments for COVID-19 ... estimates for the pricing of remdesivir in the treatment of COVID-19 that would represent a "cost recovery" approach. ...
  4. NLM Digital Collections - Special assessment of outpatient treatments for COVID-19 : nirmatrelvir/ritonavir (Paxlovid) .... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, December 20, 2022
    Special assessment of outpatient treatments for COVID-19 : nirmatrelvir/ritonavir (Paxlovid) health-benefit price benchmark update ... Special assessment of outpatient treatments for COVID-19 : ... D., author. Campbell, Jonathan D., author. Richardson, Marina, author. ...
  5. NLM Digital Collections - Understanding coverage considerations for COVID-19 vaccines and treatments 
    Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, August 2022
    ... Cost Savings COVID-19 -- economics COVID-19 Drug Treatment COVID-19 Vaccines -- economics Insurance Coverage -- economics Drug Approval ... gov/news-events/press-announcements/fda-approves-first- treatment-covid-19; last accessed July 6, 2022. 4 Gottlieb ...
  6. NLM Digital Collections - Understanding coverage considerations for COVID-19 vaccines and treatments 
    Publication: Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, May 2023
    ... Benjamin D., author. Cost Savings COVID-19 Drug Treatment COVID-19 -- economics COVID-19 Vaccines -- economics Insurance Coverage ... gov/news-events/press-announcements/fda-approves-first- treatment-covid-19; last accessed July 6, 2022. 53 Gottlieb ...
  7. ... room and board, laboratory testing, imaging and intravenous therapies. ¢ COVID-19 outpatient: This pathway captures the typical total ... used 2020-2021 data from its FH® Total Treatment Cost COVID-19 benchmarks. Regional costs were based on the ...
  8. NLM Digital Collections - Business of healthcare 
    Publication: [Toronto, Ontario] : Thomson Reuters, 18-December-2023
    ... drugs by Feb. 1, 2024. Pfizer to Price COVID Treatment Paxlovid at $1,390 Per Course (Reuters) - Pfizer ... 2, 2023). [FN38] . Michael Erman, Pfizer to price COVID treatment Paxlovid at $1,390 per course, Reuters (October ...
  9. NLM Digital Collections - Assessing COVID-19-related symptoms in outpatient adult and adolescent subjects in clinical ... 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, September 2020
    ... Administration. Clinical Trials as Topic COVID-19 -- drug therapy COVID-19 -- prevention & control Outpatients FDA plays a critical ... drugs or biological products for the prevention or treatment of COVID-19 in outpatient adult and adolescent subjects. This ...
  10. NLM Digital Collections - COVID-19 : developing drugs and biological products for treatment or prevention 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, February 2021
    ... and Drug Administration. Biological Products COVID-19 -- drug therapy COVID-19 -- prevention & control Drug Industry FDA plays a ... in the clinical development of drugs for the treatment of COVID-19 beyond the termination of the COVID-19 ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last